AAAAAA
Results:
1-25
|
Results: 25
Authors:
Youle, M
Citation: M. Youle, Salvage treatment in HIV disease, INT J STD A, 12(5), 2001, pp. 286-292
Authors:
Churchill, DR
Slade, PM
Youle, M
Gazzard, BG
Wcber, JN
Citation: Dr. Churchill et al., A phase I/II study of the safety and activity of a microsphere formulationof KNI-272 in patients with HIV-1 infection, J ANTIMICRO, 47(3), 2001, pp. 353-355
Authors:
Schrooten, W
Colebunders, R
Youle, M
Molenberghs, G
Dedes, N
Koitz, G
Finazzi, R
de Mey, I
Florence, E
Dreezen, C
Citation: W. Schrooten et al., Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment, AIDS, 15(8), 2001, pp. 1019-1023
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Mocroft, A
Youle, M
Moore, A
Sabin, CA
Madge, S
Lepri, AC
Tyrer, M
Chaloner, C
Wilson, D
Loveday, C
Johnson, MA
Phillips, AN
Citation: A. Mocroft et al., Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre, AIDS, 15(2), 2001, pp. 185-194
Authors:
Teo, SK
Harden, JL
Burke, AB
Noormohamed, FH
Youle, M
Johnson, MA
Peters, BS
Stirling, DI
Thomas, SD
Citation: Sk. Teo et al., Thalidomide is distributed into human semen after oral dosing, DRUG META D, 29(10), 2001, pp. 1355-1357
Authors:
Veldkamp, AI
Harris, M
Montaner, JSG
Moyle, G
Gazzard, B
Youle, M
Johnson, M
Kwakkelstein, MO
Carlier, H
van Leeuwen, R
Beijnen, JH
Lange, JMA
Reiss, P
Hoetelmans, RMW
Citation: Ai. Veldkamp et al., The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons, J INFEC DIS, 184(1), 2001, pp. 37-42
Authors:
Youle, M
Holtzer, C
Simpson, K
de Clerq, K
Miller, V
Citation: M. Youle et al., HIV-1 drug resistance testing: health outcomes issues, ANTIVIR TH, 5(2), 2000, pp. 113-115
Authors:
Costello, C
Pourgourides, E
Youle, M
Citation: C. Costello et al., Amyl nitrite induced acute haemolytic anaemia in HIV-antibody positive man, INT J STD A, 11(5), 2000, pp. 334-335
Authors:
Devereux, HL
Loveday, C
Youle, M
Sabin, CA
Burke, A
Johnson, M
Citation: Hl. Devereux et al., Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients, AIDS RES H, 16(11), 2000, pp. 1025-1030
Authors:
Youle, M
Citation: M. Youle, Is interruption of HIV therapy always harmful?, J ANTIMICRO, 45(2), 2000, pp. 137-138
Authors:
Youle, M
Janossy, G
Turnbull, W
Tilling, R
Loveday, C
Mocroft, A
Tyrer, M
Madge, S
Wilson, D
Dykhoff, A
Johnson, M
Phillips, AN
Citation: M. Youle et al., Changes in CD4 lymphocyte counts after interruption of therapy in patientswith viral failure on protease inhibitor-containing regimens, AIDS, 14(12), 2000, pp. 1717-1720
Authors:
Mocroft, A
Devereux, H
Kinloch-de-Loes, S
Wilson, D
Madge, S
Youle, M
Tyrer, M
Loveday, C
Phillips, AN
Johnson, MA
Citation: A. Mocroft et al., Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population, AIDS, 14(11), 2000, pp. 1545-1552
Authors:
Marshall, DA
Simpson, KN
Norton, EC
Biddle, AK
Youle, M
Citation: Da. Marshall et al., Measuring the effect of clinical guidelines on patient outcomes, INT J TE A, 16(4), 2000, pp. 1013-1023
Authors:
Devereux, HL
Loveday, C
Youle, M
Sabin, CA
Burke, A
Johnson, MA
Citation: Hl. Devereux et al., Reduction in human immunodeficiency virus type 1 mutations associated withdrug resistance after initiating new therapeutic regimens in pretreated patients, J INFEC DIS, 181(5), 2000, pp. 1804-1807
Authors:
Jackson, TL
Meacock, W
Youle, M
Graham, EM
Citation: Tl. Jackson et al., Severe intraocular inflammation after a change of HAART, BR J OPHTH, 84(8), 2000, pp. 933-934
Authors:
Mocroft, A
Sabin, CA
Youle, M
Madge, S
Tyrer, M
Devereux, H
Deayton, J
Dykhoff, A
Lipman, MCI
Phillips, AN
Johnson, MA
Citation: A. Mocroft et al., Changes in AIDS-defining illnesses in a London clinic, 1987-1998, J ACQ IMM D, 21(5), 1999, pp. 401-407
Authors:
Ball, JK
Rowe, T
Curran, R
Irving, WL
Beards, GM
Sontag, G
Youle, M
Moyle, G
Pillay, D
Citation: Jk. Ball et al., Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy, SEX TRANS I, 75(5), 1999, pp. 337-339
Authors:
Youle, M
Citation: M. Youle, Health economics in HIV disease, ANTIVIR TH, 4, 1999, pp. 43-47
Authors:
Youle, M
Trueman, P
Simpson, K
Citation: M. Youle et al., Health economics in HIV disease - A review of the European literature, PHARMACOECO, 15, 1999, pp. 1-12
Authors:
Lacey, L
Youle, M
Trueman, P
Staszewski, S
Schrappe, M
Behrens, M
Citation: L. Lacey et al., A prospective evaluation of the cost effectiveness of adding lamivudine tozidovudine-containing antiretroviral treatment regimens in HIV infection -European perspective, PHARMACOECO, 15, 1999, pp. 39-53
Authors:
Devereux, HL
Youle, M
Johnson, MA
Loveday, C
Citation: Hl. Devereux et al., Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy, AIDS, 13(18), 1999, pp. F123-F127
Authors:
Mocroft, A
Barry, S
Sabin, CA
Lepri, AC
Kinloch, S
Drinkwater, A
Lipman, M
Youle, M
Johnson, MA
Phillips, AN
Citation: A. Mocroft et al., The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997, AIDS, 13(10), 1999, pp. 1255-1261
Authors:
Lister, RK
Youle, M
Nair, DR
Winder, AF
Rustin, MHA
Citation: Rk. Lister et al., Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors, LANCET, 353(9165), 1999, pp. 1678-1678
Authors:
Youle, M
Citation: M. Youle, Didanosine once daily: an overview, ANTIVIR TH, 3, 1998, pp. 35-37
Risultati:
1-25
|